Seven-Fraction Radiotherapy Non-Inferior to Standard Care
Seven-Fraction Radiotherapy Non-Inferior to Standard Care BLUF (Bottom Line Up Front) A landmark 10-year study confirms that ultra-short radiation therapy (7 treatments over 2.5 weeks) is just as effective as conventional radiation (39 treatments over 8 weeks) for intermediate- and high-risk prostate cancer patients receiving definitive treatment to an intact prostate, with slightly better outcomes and no increase in side effects. However, the situation is different for men receiving salvage radiation after prostatectomy—shorter schedules are being studied but conventional fractionation remains the established standard of care. Meanwhile, PSMA PET/CT imaging is revolutionizing how radiation is planned and delivered in both settings, enabling more precise targeting and improved outcomes. This article explains what patients need to know about all three developments. Ultra-Short Radiation Therapy Proves Equal to Standard Treatment After 10 Years: What Prostate Cancer Patients Need to K...